Anakinra and Rilonacept: Interaction Details
AI-assisted, pharmacist-reviewed · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Anakinra
Rilonacept
No brand names on recordHow we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What happens
An increased risk of serious infections
Interaction Deep Dive
Concomitant use of rilonacept (an interleukin (IL)-1 blocking agent) and other IL-1 blocking agents, including anakinra, is not recommended due to an increased risk of serious infection. Although data are not available on the effects of concurrent rilonacept and IL-1 blocking agents, there is the potential for pharmacologic interactions between rilonacept and recombinant IL-1 receptor antagonists1.
Why it happens (mechanism)
Unknown
Common questions
Can I take Anakinra and Rilonacept together?
An increased risk of serious infections Always confirm with your pharmacist or prescriber before making any change.
How serious is the Anakinra and Rilonacept interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Anakinra or Rilonacept need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: ARCALYST(TM) subcutaneous injection, rilonacept subcutaneous injection. Regeneron Pharmaceuticals,Inc, Tarrytown, NY, 2008. DailyMed
Keep reading about Anakinra
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist